May 19, 2017
1 min read

Smoking cessation 4 years prior to RA diagnosis associated with reduced mortality risk

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Smoking cessation 4 years prior to a diagnosis of rheumatoid arthritis was linked to a reduced mortality risk, according to a recently published analysis.

Jeffrey A. Sparks, MD, MMSc , from Brigham and Women’s Hospital and Harvard Medical School, and colleagues enrolled 121,701 registered nurses in 1976 who answered questionnaires every 2 years. Among the nurses, 938 had incident rheumatoid arthritis (RA). There were 8,951 matched controls.

Among those who smoked at baseline, 40% of participants with RA permanently quit smoking in the early period, compared with 36.1% of the control group. In addition, 33.4% of the RA group died; whereas, 22.8% of the control group died. Compared with smoking continuation, smoking cessation 4 years prior to diagnosis was linked with reduced mortality for the RA group (ratio = 0.58) and in the control group (ratio = 0.47). In addition, women with RA had an increased mortality after smoking at least five packs per day after RA diagnosis compared with those who did not smoke (ratio = 1.88).

“These results demonstrate the mortality burden from smoking for RA patients, beyond the effect observed in the general population,” the researchers wrote. – by Will A. Offit

Disclosure : The researchers report no relevant financial disclosures.